Literature DB >> 26364968

A randomized, controlled trial to compare the efficacy and safety profile of a dexmedetomidine-ketamine combination with a propofol-fentanyl combination for ERCP.

Rakhee Goyal1, Shahbaz Hasnain1, Saloni Mittal1, Sharad Shreevastava2.   

Abstract

BACKGROUND AND AIMS: Moderate to deep levels of sedation and analgesia are required for ERCP. Propofol-based sedation is simple, easy to use, and effective, but is not without cardiovascular and respiratory adverse effects. The combination of dexmedetomidine and ketamine (DK) has shown promising results for sedation in other similar scenarios. The aim of this study was to compare the efficacy and safety of a standard propofol-fentanyl (PF) regimen with a DK combination.
METHODS: After approval of the hospital ethics committee, 83 patients (18-75 years of age) were randomized and divided into 2 groups. Forty-two patients received a PF combination (group PF) and 41 patients received DK combination (group DK) for total intravenous anesthesia for ERCP as initial boluses followed by an infusion of PF and DK, respectively. The sedation-related adverse effects and recovery time were noted.
RESULTS: The mean values of the hemodynamic and respiratory parameters were in clinically acceptable ranges, but there were more episodes of hypotension (19%), bradycardia (4.7%), and decrease in oxygen saturation (Spo(2) <80% in 11.9% and Spo(2) <90% for >10 s in 42.8%) in group PF. The procedure could be completed in all of the patients but was interrupted in 6 patients in group PF because of desaturation (5) or sudden patient movement (1). The recovery time was longer in group DK than in group PF.
CONCLUSION: There were significantly fewer sedation-related adverse effects, but the recovery time was longer with DK.
Copyright © 2016 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26364968     DOI: 10.1016/j.gie.2015.08.077

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  5 in total

1.  Efficacy of a Dexmedetomidine-Remifentanil Combination Compared with a Midazolam-Remifentanil Combination for Conscious Sedation During Therapeutic Endoscopic Retrograde Cholangio-Pancreatography: A Prospective, Randomized, Single-Blinded Preliminary Trial.

Authors:  Zhiqiang Lu; Wenyuan Li; Huiyu Chen; Yanning Qian
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

2.  Comparison of propofol-nalbuphine and propofol-fentanyl sedation for patients undergoing endoscopic retrograde cholangiopancreatography: a double-blind, randomized controlled trial.

Authors:  Weidong Mi; Longhe Xu; Peiqi Wang; Yan Chen; Ying Guo; Jiangbei Cao; Hong Wang
Journal:  BMC Anesthesiol       Date:  2022-02-16       Impact factor: 2.217

3.  Dexmedetomidine versus propofol sedation in flexible bronchoscopy: a randomized controlled trial.

Authors:  Barak Pertzov; Boris Krasulya; Karam Azem; Yael Shostak; Shimon Izhakian; Dror Rosengarten; Svetlana Kharchenko; Mordechai R Kramer
Journal:  BMC Pulm Med       Date:  2022-03-15       Impact factor: 3.317

Review 4.  Efficacy of propofol for the prevention of emergence agitation after sevoflurane anaesthesia in children: A meta-analysis.

Authors:  Yinggang Xiao; Xuening Jin; Yang Zhang; Tianfeng Huang; Luojing Zhou; Ju Gao
Journal:  Front Surg       Date:  2022-10-03

Review 5.  Perioperative sleep apnea: a real problem or did we invent a new disease?

Authors:  Sebastian Zaremba; James E Mojica; Matthias Eikermann
Journal:  F1000Res       Date:  2016-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.